PAPER Hwang J, Youn K, Lim G, Lee J, Kim DH, Jun M

Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches.

Nutrients. 2021 Jan 17;13(1) PubMed: 33477276

PAPER Marquez A, Guernsey LS, Frizzi KE, Cundiff M, Constantino I, Muttalib N, Arenas F, Zhou X, Lim SH, Ferdousi M, Ponirakis G, Silverdale M, Kobylecki C, Jones M, Marshall A, Malik RA, Jolivalt CG

Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.

Neurobiol Dis. 2021 Jan 19;151:105273. PubMed: 33482356

PAPER Tozzi F, Rutigliano G, Borsò M, Falcicchia C, Zucchi R, Origlia N

T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex.

Neurobiol Dis. 2021 Jan 19;151:105271. PubMed: 33482355

PAPER Fakhree MA, Konings IB, Kole J, Cambi A, Blum C, Claessens MM

The Localization of Alpha-synuclein in the Endocytic Pathway.

Neuroscience. 2021 Mar 1;457:186-195. Epub 2021 Jan 20 PubMed: 33482328

PAPER Limegrover CS, Yurko R, Izzo NJ, LaBarbera KM, Rehak C, Look G, Rishton G, Safferstein H, Catalano SM

Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.

J Neurosci Res. 2021 Apr;99(4):1161-1176. Epub 2021 Jan 22 PubMed: 33480104

PAPER Yoseph M, Paddick SM, Gray WK, Andrea D, Barber R, Colgan A, Dotchin C, Urasa S, Kisoli A, Kissima J, Haule I, Rogathi J, Safic S, Mushi D, Robinson L, Walker RW

Prevalence estimates of dementia in older adults in rural Kilimanjaro 2009-2010 and 2018-2019: is there evidence of changing prevalence?

Int J Geriatr Psychiatry. 2021 Jan 22; PubMed: 33480089

PAPER Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, Rosenberg G, Sagare A, Satizabal CL, Schneider J, Seshadri S, Sur S, Tracy RP, Yasar S, Williams V, Singh H, Mazina L, Helmer KG, Corriveau RA, Schwab K, Kivisäkk P, Greenberg SM, MarkVCID Consortium

MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.

Alzheimers Dement. 2021 Jan 21; PubMed: 33480172

Tenure-Track Assistant Professor

JOB 2021-01-23 Employer Rosalind Franklin University / The Chicago Medical School Principal Investigator Grace Stutzmann Description The Center for Neurodegenerative Disease and Therapeutics at Rosalind Franklin University of Medicine and Science invites applications ...

Jimmy Yen

Scott Reid

Robert Ellingford

University College London
London, United Kingdom

PAPER Fuse T, Nakagaki T, Homma T, Tange H, Yamaguchi N, Atarashi R, Ishibashi D, Nishida N

Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection.

Neurosci Res. 2021 Jan 18; PubMed: 33476681

PAPER Griffin BA, Booth MS, Busse M, Wild EJ, Setodji C, Warner JH, Sampaio C, Mohan A

Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting.

Parkinsonism Relat Disord. 2021 Jan 13;83:56-62. PubMed: 33476879

PAPER Iwasaki Y, Mori K, Ito M, Kawai Y, Akagi A, Riku Y, Miyahara H, Kobayashi A, Kitamoto T, Yoshida M

System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.

Prion. 2021 Dec;15(1):12-20. PubMed: 33472525

PAPER Breimer P, Petersén Å, Widner H

[Recurrent psychotic symtoms over several years were caused by Huntington's disease].

Lakartidningen. 2021 Jan 19;118 PubMed: 33474718